A jury in a St. Louis court ruled in favor of Bayer, rejecting claims by three plaintiffs that linked cancer to use of the herbicide Roundup, Bloomberg reports. This is the first ruling of its kind since the US Supreme Court ruled that it limited lawsuits for the lack of cancer risk warnings on labels. The company has already spent more than $11 billion to resolve similar disputes, while about 65,000 cases remain unresolved.

A jury in a St. Louis court ruled in favor of Bayer, rejecting claims by three plaintiffs that linked cancer to use of the herbicide Roundup, Bloomberg reports. This is the first ruling of its kind since the US Supreme Court ruled that it limited lawsuits for the lack of cancer risk warnings on labels. The company has already spent more than $11 billion to resolve similar disputes, while about 65,000 cases remain unresolved.